These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24639918)

  • 21. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
    Yin X; Hu L; Feng X; Wang H; Zhang C; Wang H; Wang S
    J Oral Pathol Med; 2019 Sep; 48(8):705-711. PubMed ID: 31132188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1.
    Böhm R; Imseng S; Jakob RP; Hall MN; Maier T; Hiller S
    Mol Cell; 2021 Jun; 81(11):2403-2416.e5. PubMed ID: 33852892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
    Kodali D; Rawal A; Ninan MJ; Patel MR; Mesa H; Knapp D; Schnitzer B; Kratzke RA; Gupta P
    Arch Pathol Lab Med; 2011 Mar; 135(3):365-71. PubMed ID: 21366462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
    Jossé L; Xie J; Proud CG; Smales CM
    Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
    Wang J; Ye Q; She QB
    Cancer Cell Microenviron; 2014; 1(5):. PubMed ID: 26005705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.
    Murai A; Asa SA; Kodama A; Hirata A; Yanai T; Sakai H
    BMC Vet Res; 2012 Jul; 8():128. PubMed ID: 22839755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.
    Ferrari KL; de Camargo JA; Rocha GZ; Carvalheira JB; Saad MJ; Billis A; Reis LO
    J Urol; 2015 Feb; 193(2):682-9. PubMed ID: 25200808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implications.
    Montero JC; Chen X; Ocaña A; Pandiella A
    Mol Cancer Ther; 2012 Jun; 11(6):1342-52. PubMed ID: 22496482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1.
    Zhang L; Kimball SR; Jefferson LS; Shenberger JS
    Free Radic Biol Med; 2009 Jun; 46(11):1500-9. PubMed ID: 19281842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors.
    Nishikawa M; Miyake H; Harada K; Fujisawa M
    Med Oncol; 2014 Jan; 31(1):792. PubMed ID: 24307346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
    Nishikawa M; Miyake H; Harada K; Fujisawa M
    Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin.
    Li F; Mao X; Zhuang Q; Zhao Z; Zhang Z; Wu H
    Cell Death Dis; 2019 Mar; 10(3):241. PubMed ID: 30858353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.
    Coffman K; Yang B; Lu J; Tetlow AL; Pelliccio E; Lu S; Guo DC; Tang C; Dong MQ; Tamanoi F
    J Biol Chem; 2014 Feb; 289(8):4723-34. PubMed ID: 24403073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
    Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
    J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
    Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.